ChemicalBook >> CAS DataBase List >>SM 5887

SM 5887

CAS No.
110311-30-3
Chemical Name:
SM 5887
Synonyms
Calsed;SM 5887;AMR hydrochloride;Amrubicin hydrochloride;BHMLHEQFWVQAJS-IERVSNJOSA-N;(1S,3S)-3-Acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl2-deoxy-β-D-erythro-pentopyranosidehydrochloride(1:1);(7S,9S)-9-Acetyl-9-amino-7-(2-deoxy-β-D-erythro-pentopyranosyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione·hydrochloride
CBNumber:
CB21374151
Molecular Formula:
C25H25NO9.ClH
Molecular Weight:
519.931
MDL Number:
MOL File:
110311-30-3.mol
Last updated:2022-12-21 16:56:50

SM 5887 Properties

Melting point 145-151°
FDA UNII EUL6MP8FZW
NCI Drug Dictionary amrubicin hydrochloride

SAFETY

Risk and Safety Statements

Toxicity LD50 i.v. in mice: 32-50 mg/kg (Morisada)

SM 5887 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation API0004795 SM 5887 95.00% 110311-30-3 1MG $329.7 2021-12-16 Buy
American Custom Chemicals Corporation API0004795 SM 5887 95.00% 110311-30-3 5MG $504.74 2021-12-16 Buy
Crysdot CD31004574 Amrubicinhydrochloride 98+% 110311-30-3 5mg $290 2021-12-16 Buy
Product number Packaging Price Buy
API0004795 1MG $329.7 Buy
API0004795 5MG $504.74 Buy
CD31004574 5mg $290 Buy

SM 5887 Chemical Properties,Uses,Production

Description

small and small-cell lung cancers. Amrubicin, a completely synthetic anthracycline derivative, mediates its growth inhibitory action via topoisomerase II inhibition. It is activated in viva by the formation of its 13-OH metabolite, amrubicinol, via reaction with carbonyl reductase. In contrast to doxorubicin and daunorubicin whose metabolites are inactive in the blood, amrubicinol is 10-100 fold more cytotoxic than amrubicin. In phase II clinical trials, amrubicin showed antitumor activity against non-small-cell lung cancers (response rate exceeding 20%) and against untreated extensive stage small-cell-lung cancers (response rate 78.8%). Amrubicin demonstrated a smaller distribution-volume, a shorter half-life in mice and also less chronic cardiotoxicity in preclinical studies compared to doxorubicin. Amrubicin was generally well tolerated with major adverse events being anaemia, leucopenia, thrombocytopenia and neutropenia.

Originator

Sumitomo (Japan)

brand name

Calsed

SM 5887 Preparation Products And Raw materials

Raw materials

Preparation Products

SM 5887 Suppliers

Global( 13)Suppliers
Supplier Tel Email Country ProdList Advantage
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152 Mandy@hangyubiotech.com China 10978 58
MedChemexpress LLC 021-58955995 sales@medchemexpress.cn United States 4863 58
BOC Sciences 16314854226 info@bocsci.com United States 9926 65
Musechem +1-800-259-7612 info@musechem.com United States 4662 60
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096 1979313431@qq.com China 8416 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946 1461866103@qq.com China 16111 58
Absin Bioscience Inc. 021-38015121 15000105423 chenjw@absin.cn China 24734 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736 2853117764@qq.com China 8353 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581 sales@chemhifuture.com China 4475 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050 cb5@aikonchem.com China 10529 58
SM 5887 (7S,9S)-9-Acetyl-9-amino-7-(2-deoxy-β-D-erythro-pentopyranosyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione·hydrochloride Amrubicin hydrochloride (1S,3S)-3-Acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl2-deoxy-β-D-erythro-pentopyranosidehydrochloride(1:1) AMR hydrochloride BHMLHEQFWVQAJS-IERVSNJOSA-N Calsed 110311-30-3